{"id":"W4407700602","doi":"10.1200/jco.2025.43.5_suppl.155","title":"Rucaparib vs docetaxel (DTX) or second-generation androgen pathway inhibitor (ARPI) therapy for metastatic castration-resistant prostate cancer (mCRPC): TRITON3 final overall survival (OS) and safety.","year":2025,"lang":"en","type":"article","venue":"Journal of Clinical Oncology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":5,"is_retracted":false,"has_abstract":true,"ca_institutions":"Sunnybrook Health Science Centre; University of Toronto; Health Sciences Centre; CancerCare Manitoba; Ottawa Hospital; Princess Margaret Cancer Centre; University of Ottawa","funders":"","keywords":"Medicine; Docetaxel; Prostate cancer; Oncology; Androgen deprivation therapy; Cabazitaxel; Overall survival; Internal medicine; Abiraterone; Castration; Androgen receptor; Urology; Cancer; Hormone","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001254663,0.0006653193,0.001233017,0.0003845708,0.0002020335,0.0006724736,0.0005224008,0.0007002625,0.004668095],"category_scores_gemma":[0.001141832,0.0002696326,0.001568011,0.0004215992,0.0004847765,0.0005603757,0.0003234331,0.001686043,0.000496425],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007278221,"about_ca_system_score_gemma":0.001038062,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00069382,"about_ca_topic_score_gemma":0.002685901,"domain_scores_codex":[0.9994971,0.000256536,0.00004135226,0.00007813481,0.00004592153,0.00008101214],"domain_scores_gemma":[0.9991459,0.0002852285,0.0002680718,0.00006009846,0.00003139511,0.0002092773],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.961394,0.004822195,0.00188524,0.0003268626,0.0008271573,0.00003634096,0.00005194781,0.0006450918,0.004454548,0.000135742,0.0006946822,0.02472626],"study_design_scores_gemma":[0.5296448,0.4443005,0.01642303,0.00006057969,0.001772431,0.0001667955,0.00005886162,0.001249961,0.003862825,0.0003407291,0.00208652,0.00003290399],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.994158,0.001758153,0.000243028,0.0001879562,0.00009510516,0.0006231057,0.0009989997,0.00004318604,0.001892477],"genre_scores_gemma":[0.9962062,0.0006767471,0.0003253677,0.0002080718,0.0000860385,0.0004610152,0.0009182168,0.00001003998,0.001108345],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.004668095,"threshold_uncertainty_score":0.0156163,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.2043287372512176,"score_gpt":0.4870427981683177,"score_spread":0.2827140609171002,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}